Skip to main content

Round Table on TB and HIV Trials & Research Infrastructure At-Risk in South Africa

TB and HIV Trials

Round Table on TB and HIV Trials & Research Infrastructure At-Risk in South Africa

Treatment Action Group (TAG), Médecins Sans Frontières Southern Africa (MSF), and the South African Medical Research Council (SAMRC) hosted a round table discussion for donors and media to share information about tuberculosis (TB) and HIV trials and research infrastructure put at risk by United States government (USG) executive orders, funding suspensions, and grant terminations.

The round table was moderated by Dr. Marcus Low, the editor of Spotlight, and featured a presentation from Lindsay McKenna, TB Project Co-Director at TAG and remarks from Prof. Ntobeko Ntusi, President and CEO of the SAMRC, Prof. Linda-Gail Bekker, Director of the Desmond Tutu HIV Centre and Principal Investigator of the University of Cape Town Clinical Trials Unit, Prof. Ian Sanne, Co-Principal Investigator of the Wits HIV Research Group Clinical Trials Unit, and Dr. Tom Ellman, Director of the Southern Africa Medical Unit of MSF.

View or Download the Discussion Summary

View or Download the Presentation